Related Experiment Videos

Risk factors for cadaveric donor allograft survival in cyclosporine-prednisone-treated recipients

B D Kahan, R Mickey, S M Flechner

Transplantation Proceedings

|February 1, 1987

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Correlation between pretransplantation test dose cyclosporine pharmacokinetic profiles and posttransplantation sirolimus blood levels in renal transplant recipients.

Therapeutic drug monitoring·1999

The role of flow cytometry-detected IgG and IgM anti-donor antibodies in cardiac allograft recipients.

Transplantation·1999

Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group.

Transplantation·1999

Prophylaxis of acute renal allograft rejection using FTY720 in combination with subtherapeutic doses of cyclosporine.

Transplantation·1999

Current thinking on chronic renal allograft rejection: issues, concerns, and recommendations from a 1997 roundtable discussion.

American journal of kidney diseases : the official journal of the National Kidney Foundation·1999

Can an immunologically, nonreactive potential allograft recipient undergo transplantation without a donor-specific crossmatch?

Transplantation·1999

See all related articles